Bellerophon’s INOpulse Shows Promising Results in Patients with PH-IPF Lung Disease
Idiopathic Pulmonary Fibrosis, News, Pulmonary Hypertension
Inhaled nitric oxide (iNO) treatment with the investigational medical device INOpulse system in patients with pulmonary hypertension associated with idiopathic pulmonary fibrosis (PH-IPF) has shown promising results in a Phase 2 clinical ... Read more